A carregar...

Uveitis as a Result of MAP Kinase Pathway Inhibition

We report the case of a patient treated with dabrafenib and trametinib (mitogen-activated protein kinase pathway inhibitors) for stage 3b cutaneous melanoma who developed bilateral uveitis. Although there have been reports of ocular side effects with this class of drugs, uveitis has not been previou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Joshi, Lavnish, Karydis, Andreas, Gemenetzi, Maria, Shao, Emily H., Taylor, Simon R.J.
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3901607/
https://ncbi.nlm.nih.gov/pubmed/24474928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000357060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!